• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Signify Health Appoints Sam Pettijohn as Chief Growth Officer and Erin Kappler Kelly as Chief Compliance Officer

    7/19/21 7:45:00 AM ET
    $SGFY
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $SGFY alert in real time by email

    Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform that leverages advanced analytics, technology and nationwide healthcare provider networks, today announced the appointment of Sam Pettijohn as Chief Growth Officer and Erin Kelly as Chief Compliance Officer.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210719005208/en/

    Sam Pettijohn joins Signify Health as Chief Growth Officer (Photo: Business Wire)

    Sam Pettijohn joins Signify Health as Chief Growth Officer (Photo: Business Wire)

    As Chief Growth Officer, Sam Pettijohn will lead Signify Health's continued growth as the Company expands its suite of offerings and its market presence across the public and private healthcare markets. In addition, he will collaborate with the Company's client success and implementation teams to enhance the customer experience to drive sustainable, long-term growth.

    "Sam is a results-driven leader who brings a deep understanding of what our clients need and expect from Signify Health as a partner in helping them achieve their goals in a dynamic environment," said Kyle Armbrester, Signify Health's CEO. "He will play a valuable role in helping us continue to broaden and deepen our engagements with clients across healthcare and we are delighted to have him join the executive leadership team."

    An advocate of organizational ethics, Erin Kelly will lead the continued development and implementation of policies and procedures that ensure compliance with regulations, policies and legal requirements. In her role as Chief Compliance Officer, Erin also will play a key role in helping enable sustainable growth by leading the Company's compliance risk management function, including driving technology initiatives and overseeing internal controls and training.

    "Erin's extensive and diversified legal experience, along with her exceptional track record of managing complex healthcare business and legal strategies, makes her uniquely qualified for this role and we are delighted to welcome her to our team," said Adam McAnaney, General Counsel, Signify Health.

    Sam joins Signify Health from Cerner Corporation where he was senior vice president of client relationships with responsibility for sales, delivery and sustainment of client relationships representing more than $1 billion in total annual revenue. An accomplished sales leader, Sam spent more than 25 years at Cerner driving exceptional growth and managing high-performance teams. Prior to Cerner, he held various sales roles at LabCorp and Roche Biomedical Laboratories. Sam earned his bachelor's degree in Speech Communication from the University of Texas at Austin and is a member of the College of Healthcare Information Management Executives among other professional organizations.

    Erin brings to Signify Health a breadth of experience managing complex healthcare business, regulatory, and legal issues. She has more than twenty years of experience, and most recently served as senior legal counsel at CVS Health/Aetna Inc. supporting strategic enterprise initiatives. Previously, Erin played a critical role providing legal and regulatory guidance for Aetna and Coventry Health Care's Medicare business. She earned her JD from the University of Michigan Law School and her bachelor's degree in Psychology from the University of Notre Dame. She is a member of the Illinois Bar and the District of Columbia Bar.

    About Signify Health

    Signify Health is a leading healthcare platform that leverages advanced analytics, technology, and nationwide healthcare provider networks to create and power value-based payment programs. Our mission is to transform how care is paid for and delivered so that people can enjoy more healthy, happy days at home. Our solutions support value-based payment programs by aligning financial incentives around outcomes, providing tools to health plans and healthcare organizations designed to assess and manage risk and identify actionable opportunities for improved patient outcomes, coordination and cost-savings. Through our platform, we coordinate what we believe is a holistic suite of clinical, social, and behavioral services to address an individual's healthcare needs and prevent adverse events that drive excess cost, all while shifting services towards the home. For more information on how we are taking health homeward, visit us at signifyhealth.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20210719005208/en/

    Get the next $SGFY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SGFY

    DatePrice TargetRatingAnalyst
    8/31/2022$35.00Buy
    BTIG Research
    7/29/2022$18.00Sector Perform
    RBC Capital Mkts
    5/16/2022$19.00 → $16.00Neutral → Outperform
    Robert W. Baird
    3/30/2022$36.00Buy
    Guggenheim
    3/9/2022$27.00 → $18.00Market Perform
    Cowen & Co.
    3/9/2022$20.00 → $21.00Neutral → Buy
    UBS
    3/7/2022$34.00 → $27.00Overweight
    Piper Sandler
    2/11/2022$20.00Buy
    Goldman Sachs
    More analyst ratings

    $SGFY
    SEC Filings

    See more
    • SEC Form 15-12G filed by Signify Health Inc.

      15-12G - Signify Health, Inc. (0001828182) (Filer)

      4/10/23 8:00:50 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 25-NSE filed by Signify Health Inc.

      25-NSE - Signify Health, Inc. (0001828182) (Subject)

      3/29/23 1:33:54 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form S-8 POS filed by Signify Health Inc.

      S-8 POS - Signify Health, Inc. (0001828182) (Filer)

      3/29/23 9:06:55 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SGFY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BTIG Research initiated coverage on Signify Health with a new price target

      BTIG Research initiated coverage of Signify Health with a rating of Buy and set a new price target of $35.00

      8/31/22 7:23:52 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • RBC Capital Mkts initiated coverage on Signify Health with a new price target

      RBC Capital Mkts initiated coverage of Signify Health with a rating of Sector Perform and set a new price target of $18.00

      7/29/22 7:24:40 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Signify Health upgraded by Robert W. Baird with a new price target

      Robert W. Baird upgraded Signify Health from Neutral to Outperform and set a new price target of $16.00 from $19.00 previously

      5/16/22 7:32:22 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SGFY
    Leadership Updates

    Live Leadership Updates

    See more
    • Type 2 Diabetes Reversal Leader Virta Health Appoints Shane Henderson as Chief Technology Officer

      A 30+ year industry veteran from Signify Health and Match.com, Shane joins to scale Virta's technology platform amid triple-digit year-over-year growth Today, diabetes reversal leader Virta Health announced the addition of Shane Henderson as Chief Technology Officer (CTO). With over three decades of experience at companies like Signify Health and Match.com, Shane joins to scale Virta's technology through continued triple-digit growth and surging demand for its innovative approach to treating metabolic diseases like type 2 diabetes, prediabetes, and obesity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220510006160/en/As CTO, S

      5/10/22 12:14:00 PM ET
      $MTCH
      $SGFY
      Computer Software: Programming Data Processing
      Technology
      Retail: Computer Software & Peripheral Equipment
    • GoodCell Appoints Chris Garcia as New CEO

      WALTHAM, Mass., Sept. 1, 2021 /PRNewswire/ -- GoodCell, a medically-actionable health technology service to proactively identify, track and address health risks, today announces it has appointed Chris Garcia as its new Chief Executive Officer and member of the Board of Directors, effective immediately. In his new role, Mr. Garcia will work to scale GoodCell's commercial strategy, while founder Trevor Perry will assume the title of President and remain as a director of the company. "The Board of Directors and I are excited to have Chris lead our organization into its next chapter of development," said Mr. Perry.  "Chris' addition validates the value of what we have built at GoodCell to date a

      9/1/21 12:00:00 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Signify Health Appoints Seasoned Tech Executive Arnold Goldberg to Board of Directors

      Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform that leverages advanced analytics, technology and nationwide healthcare provider networks, today announced the appointment of Arnold Goldberg as an independent member of its board of directors, serving on the audit committee. Most recently serving as Senior Vice President, Chief Product Architect and Senior Technologist at PayPal, Mr. Goldberg brings deep knowledge of platform architecture and product strategy to Signify Health, as well as valuable experience leading and scaling teams of technologists for some of the biggest and most groundbreaking technology companies of the past two decades. This press release fea

      8/25/21 4:35:00 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SGFY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CVS Health to Close Acquisition of Signify Health

      WOONSOCKET, R.I. and DALLAS and NEW YORK, March 27, 2023 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced it expects to complete its acquisition of Signify Health (NYSE:SGFY) on or around March 29, 2023, subject to the satisfaction or waiver of the remaining customary closing conditions set forth in the merger agreement. The companies entered into a definitive agreement in September 2022 under which CVS Health announced it would acquire Signify Health for $30.50 per share in cash for a total transaction value of approximately $8 billion. Upon completion of the acquisitio

      3/27/23 6:45:00 AM ET
      $CVS
      $SGFY
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Cardinal Health's Outcomes™ collaborates with Signify Health to offer in-home medication therapy management

      DUBLIN, Ohio, March 6, 2023 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced its collaboration with Signify Health (NYSE:SGFY) to offer in-home clinical and medication management services through its Outcomes™ business. This collaboration will help reduce costs and eliminate gaps in care for more than 2.3 million members nationwide to support their treatment journey from prescription to pharmacy to home. Studies have shown that many members do not take their medications as prescribed. Bringing together Signify Health's1 mobile network of 11,000+ credentialed clinicia

      3/6/23 9:03:00 AM ET
      $CAH
      $SGFY
      Other Pharmaceuticals
      Health Care
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Addus HomeCare Names Heather Dixon to Board of Directors

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced that Heather Dixon, CPA, has been appointed to the Company's Board of Directors as an independent board member, effective March 1, 2023. She fills the seat previously held by Steven Geringer and will serve as a member of the Audit Committee. Dixon currently serves as Chief Financial Officer of Everside Health, one of the nation's largest direct primary care providers. In this role, she provides financial oversight and strategic direction with a focus on growth and innovation within the direct primary care space. Prior to joining Everside, she was the Senior Vice President, Global Controller and Chie

      3/1/23 8:00:00 AM ET
      $ADUS
      $SGFY
      Medical/Nursing Services
      Health Care
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SGFY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $SGFY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form SC 13G/A filed by Signify Health Inc. (Amendment)

      SC 13G/A - Signify Health, Inc. (0001828182) (Subject)

      2/1/23 4:31:29 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form SC 13G filed by Signify Health Inc.

      SC 13G - Signify Health, Inc. (0001828182) (Subject)

      2/11/22 4:03:03 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form SC 13G/A filed by Signify Health Inc. (Amendment)

      SC 13G/A - Signify Health, Inc. (0001828182) (Subject)

      2/9/22 3:00:56 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 4 filed by Builder Josh

      4 - Signify Health, Inc. (0001828182) (Issuer)

      3/29/23 9:07:54 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 4 filed by Armbrester Bradford Kyle

      4 - Signify Health, Inc. (0001828182) (Issuer)

      3/29/23 9:03:24 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 4 filed by Rothman Marc D

      4 - Signify Health, Inc. (0001828182) (Issuer)

      3/29/23 9:02:41 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SGFY
    Financials

    Live finance-specific insights

    See more
    • CVS Health to Acquire Signify Health

      Advances long-term strategy by providing platform for growth in value-based care WOONSOCKET, R.I., DALLAS and NEW YORK, Sept. 5, 2022 /PRNewswire/ -- CVS Health® (NYSE:CVS) and Signify Health (NYSE:SGFY) ("Signify") have entered into a definitive agreement under which CVS Health will acquire Signify Health for $30.50 per share in cash, representing a total transaction value of approximately $8 billion. Signify Health is a leader in Health Risk Assessments, value-based care and provider enablement. With a network of more than 10,000 clinicians across all 50 states and a nationw

      9/5/22 5:00:00 PM ET
      $CVS
      $SGFY
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Signify Health Announces Second Quarter 2022 Results

      Financial Highlights Second Quarter 2022: Revenue of $246.2 million, an increase of 16% from second quarter 2021 GAAP net loss of $490.0 million, which includes a $519.9 million loss on impairment related to our decision to exit the Episodes of Care Services segment. Non-GAAP adjusted EBITDA1 of $62.6 million, an increase of 15% from second quarter 2021 2022 Guidance: Signify Health is providing guidance for full year 2022 as follows: Home & Community Services (HCS) segment revenue in the range of $800 million to $810 million; Revenue from the Caravan Health acquisition in the range of $45 million to $48 million; Adjusted EBITDA margin1 for HCS and Caravan Health of 29% to 3

      8/3/22 4:35:00 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Signify Health to Report Second Quarter 2022 Earnings and Host Earnings Call on Thursday, August 4, 2022

      Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, announced that it will release its financial results for the second quarter 2022 after the market closes on Wednesday, August 3, 2022, and will hold a conference call at 8:30am ET on Thursday, August 4, 2022 to discuss the results. Pre-registration is required for participation in the conference call. Please follow the link below to pre-register. After registering, you will be provided with your access details via email. http://www.incommuk.com/customers/signifyhealthquartertwo2022 A webcast of the conference call will also be available

      7/20/22 4:35:00 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology